QCR10 Antibody

What is QCR10 and why is it a significant target for antibody-based research?

QCR10 is a nuclear gene encoding an 8.5-kDa protein that functions as a subunit of the cytochrome bc1 complex (Complex III) in Saccharomyces cerevisiae. The protein consists of 77 amino acids with a predicted molecular mass of 8492 Da and contains a distinctive 63-base pair intron that separates the codons for the amino-terminal methionine and alanine from the remainder of the open reading frame .

QCR10 plays a critical role in maintaining the functionality of the respiratory chain, as its deletion reduces ubiquinol-cytochrome c oxidoreductase activity by approximately 40% in mitochondrial membranes. More significantly, QCR10 is required for stable association of the Rieske iron-sulfur protein with the complex, making it an important target for studying mitochondrial respiratory chain assembly and function .

Research applications using QCR10 antibodies include investigating mitochondrial biogenesis, analyzing respiratory chain defects, and studying the evolutionary conservation of cytochrome bc1 complex assembly across species.

What types of QCR10 antibodies are available for research applications?

Based on available information, QCR10 antibodies used in research primarily include rabbit polyclonal antibodies . Polyclonal antibodies offer several advantages for detecting proteins like QCR10:

• They recognize multiple epitopes, increasing detection sensitivity for low-abundance proteins

• They can be more robust against minor changes in protein conformation

• They often work across multiple applications (Western blotting, immunoprecipitation, etc.)

When selecting a QCR10 antibody, researchers should consider:

• Host species (rabbit being the documented option)

• Validated applications specific to your research needs

• Cross-reactivity with homologous proteins in other species (particularly important given the 28% identity between yeast QCR10 and bovine heart cytochrome bc1 complex subunit 11)

• Epitope location and accessibility in various experimental conditions

What are the optimal storage and handling conditions for QCR10 antibodies?

To maintain QCR10 antibody activity and specificity, researchers should follow these storage and handling guidelines:

For long-term storage integrity:

• Store antibodies in their original buffer conditions unless otherwise specified

• Add glycerol (final concentration 30-50%) if preparing aliquots for extended storage

• Include preservatives such as sodium azide (0.02-0.05%) if not already present

• Label aliquots with date, concentration, and dilution information

• Monitor for signs of degradation such as precipitation or loss of activity

What controls are essential when working with QCR10 antibodies?

Implementing proper controls is critical for generating reliable results with QCR10 antibodies:

• Positive controls:

  • Wild-type yeast samples known to express QCR10

  • Purified recombinant QCR10 protein (if available)

  • Cells or tissues with confirmed QCR10 expression

• Negative controls:

  • QCR10 knockout/deletion yeast strains

  • Secondary antibody-only controls (omitting primary antibody)

  • Peptide competition/blocking experiments to demonstrate specificity

  • Pre-immune serum (for polyclonal antibodies)

• Loading and normalization controls:

  • For Western blotting, include housekeeping proteins (GAPDH, β-actin)

  • For mitochondrial studies, use established mitochondrial markers (VDAC, COX IV)

  • Total protein staining methods (Ponceau S, SYPRO Ruby)

• Technical replicates:

  • Run at least three biological replicates for quantitative experiments

  • Include technical replicates to assess procedural variability

Proper documentation of all controls is essential for result interpretation and troubleshooting.

What is the recommended methodology for validating QCR10 antibody specificity?

Validating antibody specificity is crucial before undertaking substantial research projects. For QCR10 antibodies, a comprehensive validation strategy includes:

• Western blot analysis:

  • Compare band patterns between wild-type and QCR10 knockout samples

  • Verify the presence of a single band at the expected molecular weight (~8.5 kDa)

  • Test different sample types (whole cell lysates vs. isolated mitochondria)

• Peptide competition:

  • Pre-incubate antibody with excess immunizing peptide or recombinant QCR10

  • Run parallel Western blots or immunostaining with blocked and unblocked antibody

  • Specific signals should disappear or significantly diminish in blocked samples

• Mass spectrometry validation:

  • Immunoprecipitate using QCR10 antibody

  • Subject isolated proteins to mass spectrometry analysis

  • Confirm QCR10 presence and identify potential cross-reactive proteins

• Cross-species reactivity assessment:

  • Test antibody against samples from different species if cross-reactivity is suspected

  • Compare results with sequence homology predictions (e.g., the 28% identity with bovine subunit 11)

Systematic documentation of validation experiments establishes confidence in antibody specificity and experimental reproducibility.

How can QCR10 antibodies be employed to study cytochrome bc1 complex assembly?

QCR10 antibodies provide powerful tools for investigating the assembly pathways of the cytochrome bc1 complex (Complex III) of the respiratory chain. Based on findings that QCR10 is required for stable association of the Rieske iron-sulfur protein with the complex , these antibodies can be used in several sophisticated approaches:

• Blue Native PAGE coupled with immunoblotting:

  • Separate intact respiratory complexes under native conditions

  • Probe with QCR10 antibodies to identify complex assemblies containing this subunit

  • Compare complex distribution between wild-type and mutant strains

  • Detect assembly intermediates that accumulate in assembly factor mutants

• Sucrose gradient fractionation:

  • Separate mitochondrial protein complexes by density

  • Analyze fractions by Western blotting with QCR10 antibodies

  • Map QCR10's association with various assembly intermediates

  • Compare profile with other complex subunits to determine assembly sequence

• Immunoprecipitation-based interactome studies:

  • Use QCR10 antibodies to pull down the protein and its interacting partners

  • Analyze co-precipitating proteins by mass spectrometry

  • Identify novel assembly factors or temporal assembly associations

  • Compare interactomes between different genetic backgrounds or conditions

• Pulse-chase studies:

  • Monitor incorporation of newly synthesized QCR10 into the complex over time

  • Use antibodies to track assembly progression

  • Determine rate-limiting steps in complex formation

These approaches can provide critical insights into the temporal sequence of complex assembly, identify assembly factors, and reveal how mutations affect respiratory chain formation.

What methods can be used to investigate QCR10's role in Rieske iron-sulfur protein stability?

The search results indicate that QCR10 plays a crucial role in stabilizing the association of the Rieske iron-sulfur protein with the cytochrome bc1 complex . To investigate this relationship, researchers can employ several methodological approaches:

• Co-immunoprecipitation studies:

  • Use QCR10 antibodies to pull down protein complexes

  • Probe for Rieske protein in immunoprecipitates by Western blotting

  • Compare wild-type samples with those carrying mutations in QCR10

  • Quantify relative amounts of co-precipitated Rieske protein

• Proximity labeling techniques:

  • Use enzymatic proximity labeling methods (BioID, APEX) with QCR10 as the bait

  • Identify proteins in close proximity to QCR10 in vivo

  • Confirm direct or indirect associations with the Rieske protein

  • Map interaction domains through truncation mutants

• Structural analysis:

  • Utilize QCR10 antibodies to verify the presence of QCR10 in purified complexes for structural studies

  • Perform cryo-EM or X-ray crystallography on complexes with and without QCR10

  • Determine the structural changes that occur in the absence of QCR10

  • Map the interaction interface between QCR10 and the Rieske protein

• Functional impact assessment:

  • Measure enzymatic activities in the presence and absence of QCR10

  • Correlate Rieske protein levels with complex activity

  • Investigate whether stabilization is dependent on specific QCR10 domains

  • Determine if other proteins can compensate for QCR10 loss

These methodologies can help elucidate the molecular mechanism by which QCR10 contributes to complex stability and function.

How do QCR10 antibodies perform in comparative studies across different species?

The moderate sequence conservation between yeast QCR10 and mammalian homologs (28% identity with bovine subunit 11) creates both challenges and opportunities for cross-species studies. When using QCR10 antibodies across species, researchers should consider:

• Cross-reactivity assessment:

  • Test antibody specificity against samples from multiple species

  • Confirm expected molecular weight differences (8.5 kDa in yeast vs. 6.4 kDa for bovine subunit 11)

  • Validate with knockout/knockdown controls from each species when possible

  • Perform peptide competition assays to confirm specificity

• Epitope conservation analysis:

  • Conduct bioinformatic analysis of epitope conservation across species

  • Select antibodies raised against conserved regions for cross-species applications

  • Consider using multiple antibodies targeting different epitopes

  • Verify that secondary structure similarities (noted between yeast and bovine proteins) translate to epitope recognition

• Optimization for each species:

  • Adjust antibody concentrations for each species

  • Modify extraction and sample preparation protocols

  • Optimize blocking conditions to minimize background

  • Consider species-specific modifications to standard protocols

• Data interpretation:

  • Account for differences in protein abundance between species

  • Consider evolutionary differences in complex composition and assembly

  • Interpret results in the context of known functional differences

  • Use orthogonal approaches to confirm key findings

A systematic approach to cross-species antibody validation enhances the reliability of comparative studies and can reveal evolutionary insights into respiratory chain assembly and function.

What approaches are recommended for studying interactions between QCR10 and other cytochrome bc1 complex components?

Investigating protein-protein interactions within large complexes like cytochrome bc1 requires sophisticated methodological approaches. For studying QCR10's interactions:

• In vivo crosslinking coupled with immunoprecipitation:

  • Treat intact cells/mitochondria with membrane-permeable crosslinkers

  • Immunoprecipitate with QCR10 antibodies

  • Analyze crosslinked products by Western blotting or mass spectrometry

  • Map direct binding partners through crosslinker distance constraints

• Yeast two-hybrid or split-reporter assays:

  • Screen for direct interactions between QCR10 and other complex components

  • Validate interactions in mammalian cells using bimolecular fluorescence complementation

  • Map interaction domains through deletion constructs

  • Assess the impact of disease-associated mutations on interaction strength

• Quantitative binding studies:

  • Express and purify recombinant QCR10 and potential binding partners

  • Perform surface plasmon resonance or isothermal titration calorimetry

  • Determine binding affinities and thermodynamic parameters

  • Compare wild-type interactions with mutant proteins

• Computational modeling:

  • Use existing structural data on cytochrome bc1 complex

  • Perform molecular docking to predict interaction interfaces

  • Design mutations to test predicted interactions

  • Validate computational predictions experimentally using QCR10 antibodies

• Genetic interaction studies:

  • Expand on the observed synergistic effects between QCR10 and QCR6 deletions

  • Create double mutants between QCR10 and other complex components

  • Characterize growth phenotypes and complex stability

  • Use QCR10 antibodies to assess protein levels in various genetic backgrounds

These approaches can reveal the molecular details of how QCR10 contributes to complex stability, particularly its role in stabilizing the association of the Rieske iron-sulfur protein.

How can QCR10 antibodies contribute to understanding respiratory chain defects in disease models?

QCR10 antibodies can provide valuable insights into respiratory chain dysfunction in various disease models, particularly those related to mitochondrial disorders:

• Complex assembly analysis in patient samples:

  • Compare cytochrome bc1 complex assembly in control vs. patient samples

  • Use QCR10 antibodies in conjunction with antibodies against other complex components

  • Identify specific assembly defects through subunit profiling

  • Correlate assembly abnormalities with enzymatic deficiencies

• Genetic rescue experiments:

  • Introduce wild-type or mutant QCR10 into deficient cells

  • Assess complex recovery using QCR10 antibodies

  • Measure functional restoration through activity assays

  • Determine structure-function relationships for disease-associated variants

• Pharmacological intervention studies:

  • Test compounds that might stabilize respiratory complexes

  • Use QCR10 antibodies to monitor treatment effects on complex assembly

  • Screen for drugs that may compensate for specific assembly defects

  • Develop personalized therapeutic approaches based on specific defect patterns

• Tissue-specific expression analysis:

  • Compare QCR10 expression across different tissues in disease models

  • Correlate with tissue-specific manifestations of respiratory chain defects

  • Identify compensatory mechanisms in less affected tissues

  • Target interventions to tissues with greatest molecular defects

While the search results primarily focus on yeast QCR10, the methodological approaches are applicable to studying homologous proteins in mammalian systems and disease models.

What are the optimal conditions for using QCR10 antibodies in Western blotting?

Detecting small proteins like QCR10 (8.5 kDa) by Western blotting requires specific technical considerations:

• Sample preparation:

  • Use extraction buffers containing 1-2% SDS and protease inhibitors

  • For mitochondrial enrichment, isolate mitochondria prior to lysis

  • Heat samples at 95°C for 5 minutes in reducing sample buffer

• Gel electrophoresis optimization:

  • Use high percentage (15-20%) SDS-PAGE gels

  • Consider Tricine-SDS-PAGE systems for better resolution of small proteins

  • Run gels at lower voltage (80-100V) to improve separation

• Transfer parameters:

  • Use PVDF membranes with 0.2 μm pore size (instead of 0.45 μm)

  • Perform transfer at lower voltage (30V) for longer time (overnight)

  • Add 10-20% methanol to transfer buffer to improve small protein binding

• Antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Use optimized antibody dilution (typically 1:500 to 1:2000)

  • Incubate primary antibody overnight at 4°C with gentle agitation

  • Perform extensive washing (5 x 5 minutes) between antibody incubations

• Detection considerations:

  • Use enhanced chemiluminescence with sensitive substrates

  • Consider fluorescent secondary antibodies for more quantitative analysis

  • Optimize exposure times for small, potentially low-abundance proteins

Following these guidelines will help ensure successful detection of QCR10 despite its small size and potentially low abundance in some samples.

What methodological approaches are recommended for immunoprecipitation of QCR10?

Immunoprecipitation of small mitochondrial proteins like QCR10 presents unique challenges that require specific optimization:

• Lysis buffer formulation:

  • For native conditions: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% digitonin, protease inhibitors

  • For denaturing conditions: Consider RIPA buffer with 0.1% SDS

  • Include phosphatase inhibitors if studying post-translational modifications

• Pre-clearing approach:

  • Incubate lysates with protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation before adding QCR10 antibody

  • This reduces non-specific binding in the final immunoprecipitate

• Antibody binding strategy:

  • Pre-couple QCR10 antibody to protein A/G beads (2-5 μg per reaction)

  • Incubate antibody-bead complex with pre-cleared lysate overnight at 4°C

  • Use gentle rotation to maintain suspension without damaging complexes

• Washing optimization:

  • Perform 3-5 washes with decreasing detergent concentrations

  • Maintain salt concentration to preserve specific interactions

  • Use gentle resuspension techniques to avoid bead loss

• Elution methods:

  • Mild elution: Use peptide competition if the epitope is known

  • Standard elution: 2X SDS sample buffer at 95°C for 5 minutes

  • For mass spectrometry: Consider on-bead digestion to avoid contaminants

• Analysis techniques:

  • Western blotting with antibodies against potential interaction partners

  • Silver staining followed by mass spectrometry for interactome studies

  • Activity assays to assess functional properties of immunoprecipitated complexes

These approaches help overcome the challenges associated with immunoprecipitating small mitochondrial proteins and increase the likelihood of capturing intact protein complexes.

How should researchers address cross-reactivity issues when using QCR10 antibodies?

Managing potential cross-reactivity is essential for generating reliable data with QCR10 antibodies, especially given the 28% sequence identity between yeast QCR10 and bovine subunit 11 :

• Specificity validation approaches:

  • Test antibodies against knockout/deletion samples

  • Perform peptide competition assays

  • Compare results with multiple antibodies targeting different epitopes

  • Verify that only a single band appears at the expected molecular weight

• Background reduction strategies:

  • Optimize blocking conditions (test BSA vs. milk vs. commercial blockers)

  • Adjust antibody dilution to minimize non-specific binding

  • Include competing proteins (e.g., 5% normal serum from the host species)

  • Increase washing stringency (duration, detergent concentration)

• Sample preparation considerations:

  • Enrich for mitochondria to increase target concentration

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Use fractionation techniques to reduce sample complexity

• Alternative detection strategies:

  • Consider sandwich ELISA formats for increased specificity

  • Use two-color Western blotting to distinguish specific from non-specific signals

  • Implement proximity ligation assays for in situ protein detection

• Data interpretation guidelines:

  • Always include appropriate controls in every experiment

  • Be cautious when interpreting results from complex samples

  • Validate key findings with orthogonal approaches

  • Document all experimental conditions to facilitate troubleshooting

These strategies help minimize cross-reactivity issues and ensure the reliability of experimental results with QCR10 antibodies.

What are the most effective approaches for quantitative analysis of QCR10 expression?

Accurate quantification of QCR10 expression requires rigorous methodological approaches:

• Western blot quantification:

  • Use digital image capture with a linear dynamic range

  • Employ software-based densitometry (ImageJ, Image Lab)

  • Include standard curves with purified protein when possible

  • Always normalize to appropriate loading controls:

    • Total protein stains (Ponceau S, SYPRO Ruby)

    • Mitochondrial markers (VDAC, COX IV) for mitochondrial proteins

• Sample preparation for consistent results:

  • Standardize cell/tissue lysis protocols

  • Process all samples simultaneously to reduce batch effects

  • Quantify total protein concentration before loading

  • Use consistent sample amounts across experiments

• Statistical analysis requirements:

  • Perform experiments with at least three biological replicates

  • Apply appropriate statistical tests based on data distribution

  • Report effect sizes alongside p-values

  • Consider power analysis to determine sample size requirements

• Visualization and reporting:

  • Present individual data points in addition to means/medians

  • Use consistent y-axis scales when comparing across experiments

  • Provide clear information about normalization methods

  • Report antibody dilutions, exposure times, and image processing steps

These quantification approaches ensure reproducible and reliable assessment of QCR10 expression levels across different experimental conditions.

What troubleshooting strategies are recommended for inconsistent results with QCR10 antibodies?

When encountering inconsistent results with QCR10 antibodies, a systematic troubleshooting approach is essential:

• Antibody-related factors:

  • Verify antibody storage conditions and expiration date

  • Prepare fresh working dilutions from concentrated stock

  • Test multiple antibody lots if variability is suspected

  • Consider epitope accessibility issues for this small protein

• Sample preparation variables:

  • Ensure complete protein extraction and solubilization

  • Check for protein degradation by including protease inhibitors

  • For mitochondrial proteins, verify mitochondrial enrichment quality

  • Consider the impact of post-translational modifications on epitope recognition

• Technical parameters:

  • For Western blotting:

    • Optimize transfer conditions for small proteins (8.5 kDa)

    • Test different membrane types (PVDF vs. nitrocellulose)

    • Adjust antibody concentration and incubation conditions

    • Try different blocking agents (milk vs. BSA)

  • For immunoprecipitation:

    • Test different lysis buffers with varying detergent types/concentrations

    • Adjust antibody-to-sample ratio

    • Modify wash stringency and number of washes

    • Try alternative elution methods

• Systematic documentation:

  • Maintain detailed records of experimental conditions

  • Document lot numbers of antibodies and key reagents

  • Record sample handling procedures precisely

  • Create a troubleshooting decision tree based on observed results

• Alternative approaches:

  • Consider epitope-tagged versions of QCR10 for difficult applications

  • Use orthogonal detection methods (mass spectrometry)

  • Implement proximity labeling approaches for interaction studies

  • Consult manufacturer's technical support for application-specific guidance

By systematically addressing these factors, researchers can identify and resolve issues leading to inconsistent results with QCR10 antibodies.